D2D Normative Data for Remote Assessments

NCT03206775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1271

Last updated 2020-02-18

No results posted yet for this study

Summary

Phase 1: This is a remote observational study in which participants will complete cognitive assessments developed by Posit Science. Participants will be healthy controls aged 18-65 with reliable internet access and a device that they can use to access the assessments, such as a laptop or iPad. Participants will complete up to 6 Posit Science assessments in different domains of cognition, which should last approximately 30 minutes.

Phase 2: This is an in person observational study in which participants will complete cognitive assessments developed by Posit Science. Participants will be healthy controls aged 18-80 who are fluent in English. Participants will complete batteries of cognitive assessments developed by Posit Science, which include combinations of visual, auditory, and social cognitive assessments, and self-report questionnaires. This study will be conducted at the Driven to Discover building at the Minnesota State Fair. Participation will last approximately 20 minutes.

Phase 3: Participants in Phase 3 will complete a Posit Science assessment battery and self-report questionnaires. Each participant will be asked to provide brief demographic and medical history data. Participants will be aged 18-35 and will be students at the University of Minnesota who are enrolled in the Research Experience Points program. Participants will complete the assessment battery remotely; the battery will take approximately 45-60 minutes to complete.

Phase 4: This is a pilot program to test the use of remote cognitive assessment and training in adolescents with an anxiety diagnosis and healthy controls. Participants will complete a short assessment battery, then will receive 4 hours of cognitive training over 2 weeks at home. Then they will repeat the battery. Total participation should last approximately 5 hours over 2-3 weeks and will be completed entirely remotely.

Conditions

  • Cognition

Interventions

BEHAVIORAL

Cognitive Assessments (Phase 1)

Participants will participate in up to 6 assessments in 4 domains of cognition: Processing Speed; Executive Attention; Learning and Memory; and Social Cognition. Assessments: * Visual Sweeps * Sustained Visual Attention * Associative Learning--Visual * Associative Learning--Auditory * Emotion Motion * Voice Choice

BEHAVIORAL

Cognitive Battery A (Phase 2)

Participants will complete two visual assessments, one auditory assessment, and one social cognition assessment. Then the participant will complete self-report surveys. Assessments: * On trails: Learning * Line Length Discrimination * Tap the Emotion * Sound Sweeps * BIS/BAS * TEPS * Feasibility survey

BEHAVIORAL

Cognitive Battery B (Phase 2)

Participants will complete two visual assessments, one auditory assessment, and one social cognition assessment. Then the participant will complete the complete self-report surveys. Assessments: * Visual Time Order Judgment * Target Tracker * Emotional Face * Auditory Sound Discrimination * BIS/BAS * TEPS * Feasiblity assessment

BEHAVIORAL

Cognitive Battery C (Phase 2)

Participants will complete two visual assessments, one auditory assessment, and one social cognition assessment. Then the participant willcomplete self-report surveys. Assessments: * Stroop 2AFC * Visual Task Switcher * Beep Seeker * Voice Choice * BIS/BAS * TEPS * Feasibility Survey

Sponsors & Collaborators

Principal Investigators

  • Sophia Vinogradov, MD · University of Minnesota

Eligibility

Min Age
12 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2019-03-25
Completion
2019-03-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03206775 on ClinicalTrials.gov